BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 100827)

  • 1. [Present state of the wide-field megavoltage radiotherapy of Hodgkin's disease. Fundamentals, performance, side effects (author's transl)].
    Wannenmacher M; Slanina J; Kuphal K; Bruggmoser G
    Radiologe; 1978 Oct; 18(10):371-87. PubMed ID: 100827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late effects of radiation therapy in the treatment of Hodgkin's disease.
    Kinsella TJ; Fraass BA; Glatstein E
    Cancer Treat Rep; 1982 Apr; 66(4):991-1001. PubMed ID: 6804091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of a radiation technic with an anterior mantle-shaped field and 10 MV photons].
    Micheletti E; Verzeletti L
    Radiol Med; 1983; 69(7-8):566-71. PubMed ID: 6422516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects of percutaneous radiotherapy in the area of the thorax: cardiac toxicity of mantle field irradiation].
    Huber K
    Bildgebung; 1991; 58 Suppl 1():23-5. PubMed ID: 1799841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications after megavoltage therapy of Hodgkin's disease.
    Nordman E
    Ann Clin Res; 1977 Feb; 9(1):35-8. PubMed ID: 407831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease. Results from a program in radiation therapy.
    Micaily B; Brady LW
    Am J Clin Oncol; 1984 Apr; 7(2):159-71. PubMed ID: 6422736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of the radiation load on organs and tissue in the radiotherapy of certain malignant neoplasms and lymphogranulomatosis].
    Funshteĭn LV; Vorob'ev EI; Shcherban' EI; Gracheva ND; Palladieva NM
    Med Radiol (Mosk); 1967 Jan; 12(1):35-42. PubMed ID: 5608251
    [No Abstract]   [Full Text] [Related]  

  • 10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
    Eich HT; Haverkamp U; Engert A; Kocher M; Skripnitchenko R; Brillant C; Sehlen S; Dühmke E; Diehl V; Müller RP
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):860-5. PubMed ID: 15925455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present day management and treatment of Hodgkin's disease.
    Brown KM
    Radiol Technol; 1974; 45(5):322-7. PubMed ID: 4206310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lymph node calcifications after radiation therapy of Hodgkin's disease].
    Enk C; Andersen E; Brünner S
    Ugeskr Laeger; 1980 Jan; 142(5):322. PubMed ID: 6766585
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiotherapy of malignant lymphomas].
    Kuttig H
    Rontgenblatter; 1984 Feb; 37(2):72-9. PubMed ID: 6424225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease. Modern radiotherapy techniques and their results.
    Kaplan HS
    Ser Haematol; 1973; 6(2):139-51. PubMed ID: 4131661
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications of intensive megavoltage radiotherapy for Hodgkin's disease.
    Kaplan HS; Stewart JR
    Natl Cancer Inst Monogr; 1973 May; 36():439-44. PubMed ID: 4200714
    [No Abstract]   [Full Text] [Related]  

  • 20. [The 5- and 10-year survival and long-term effects of radical radiotherapy in patients with stage I-III Hodgkin's disease].
    Aliev BM; Vasygova NF; Ivanova EM; Kaverzneva MM
    Vopr Onkol; 1984; 30(6):41-7. PubMed ID: 6741006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.